Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/07/24 → 31/12/26 |
Assessing reduced oligodendrocyte-specific cytotoxicity of peripheral blood leukocytes in patients with Multiple Sclerosis following treatment with Ofatumumab.
- Kelland, Eve (PI - Principal Investigator)
Project: Research